Subscribe
19 September 2017Americas

Video interview: Allen & Overy on the UPC and CRISPR

The Unified Patent Court (UPC) is likely to spark years of uncertainty and may even become part of the UK’s negotiations for Brexit.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Video interview: Allen & Overy on CRISPR evolution
22 September 2017   To evaluate how the CRISPR licensing landscape might evolve, parties need to analyse the current patent environment.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

More on this story

Americas
Video interview: Allen & Overy on CRISPR evolution
22 September 2017   To evaluate how the CRISPR licensing landscape might evolve, parties need to analyse the current patent environment.

More on this story

Americas
Video interview: Allen & Overy on CRISPR evolution
22 September 2017   To evaluate how the CRISPR licensing landscape might evolve, parties need to analyse the current patent environment.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility